Ternary Therapeutics
PrivateLast Round
Seed
Mar 16, 2026
Total Funding Raised
$4.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ternary Therapeutics is a biotechnology company that develops an AI-driven platform for the rational design of molecular glue therapeutics targeting immunological disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ternary Therapeutics Comparables
Compare Ternary Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TenAces Biosciences | 87% | |
| Celeris Therapeutics | 80% | |
| Magnet Biomedicine | 79% | |
Ternary Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 16, 2026 | ||||
| Seed | Feb 27, 2025 |
Key People
Founding team and executive leadership
Ternary Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pace Ventures | Seed |
| Daphni | Seed |
| UK Innovation & Science Seed Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Jun 1, 2026
Grew 25% QoQ from 12 to 15 employees.
Ternary Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ternary Therapeutics's valuation, stock price, and market status.